Fortive Co. (NYSE:FTV – Get Free Report) was the target of a large decline in short interest in June. As of June 15th, there was short interest totalling 2,180,000 shares, a decline of 6.8% from the May 31st total of 2,340,000 shares. Based on an average daily trading volume, of 1,610,000 shares, the days-to-cover ratio is presently 1.4 days.
Wall Street Analysts Forecast Growth
FTV has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. cut Fortive from an “overweight” rating to a “neutral” rating and decreased their target price for the stock from $95.00 to $90.00 in a research report on Wednesday, April 17th. Citigroup cut their price target on Fortive from $101.00 to $98.00 and set a “buy” rating for the company in a report on Thursday, April 25th. Wells Fargo & Company cut their price target on Fortive from $92.00 to $84.00 and set an “equal weight” rating for the company in a report on Thursday, April 25th. Royal Bank of Canada cut their price target on Fortive from $93.00 to $83.00 and set a “sector perform” rating for the company in a report on Thursday, April 25th. Finally, Barclays upped their price target on Fortive from $89.00 to $97.00 and gave the stock an “overweight” rating in a report on Tuesday, April 2nd. Seven investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $85.69.
Read Our Latest Analysis on FTV
Institutional Investors Weigh In On Fortive
Fortive Price Performance
Shares of FTV stock traded up $0.18 during trading hours on Tuesday, hitting $72.30. 1,940,465 shares of the company’s stock were exchanged, compared to its average volume of 1,660,008. The stock’s 50-day moving average is $75.04 and its 200-day moving average is $78.21. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.50 and a quick ratio of 1.17. The stock has a market cap of $25.45 billion, a price-to-earnings ratio of 28.58, a price-to-earnings-growth ratio of 2.17 and a beta of 1.12. Fortive has a 52 week low of $63.05 and a 52 week high of $87.10.
Fortive (NYSE:FTV – Get Free Report) last posted its quarterly earnings results on Wednesday, April 24th. The technology company reported $0.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.79 by $0.04. The business had revenue of $1.52 billion for the quarter, compared to analysts’ expectations of $1.53 billion. Fortive had a return on equity of 12.22% and a net margin of 14.68%. As a group, research analysts forecast that Fortive will post 3.8 EPS for the current year.
Fortive Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, June 28th. Stockholders of record on Friday, May 31st were given a dividend of $0.08 per share. This represents a $0.32 dividend on an annualized basis and a dividend yield of 0.44%. The ex-dividend date of this dividend was Friday, May 31st. Fortive’s dividend payout ratio is currently 12.65%.
About Fortive
Fortive Corporation designs, develops, manufactures, and services professional and engineered products, software, and services in the United States, China, and internationally. It operates in three segments: Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions. The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services, including electrical test and measurement, facility and asset lifecycle software applications, and connected worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries.
Further Reading
- Five stocks we like better than Fortive
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- RXO Shares Surge Following New Acquisition Deal
- What is a buyback in stocks? A comprehensive guide for investors
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- Investing In Preferred Stock vs. Common Stock
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for Fortive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fortive and related companies with MarketBeat.com's FREE daily email newsletter.